Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions
Identifying microbiome signatures that impact QOL in patients with EC and benign gynecological conditions increases understanding of how microbes may influence patient wellbeing. We offer preliminary findings for foundational knowledge for future opportunities on improvement of QOL through microbiome modulation.
Authors
- Niraj Gautam (ORCID: https://orcid.org/0000-0002-1675-0493)
- Melissa M. Herbst‐Kralovetz (ORCID: https://orcid.org/0000-0002-8540-5917)
- Denise J. Roe (ORCID: https://orcid.org/0000-0001-6989-6579)
- Haiyan Cui (ORCID: https://orcid.org/0000-0003-4969-4835)
- Dana M. Chase (ORCID: https://orcid.org/0000-0002-1073-8688)
- Paweł Łaniewski (ORCID: https://orcid.org/0000-0002-5190-2173)
- Nicole R. Jimenez (ORCID: https://orcid.org/0000-0001-9755-0022)
Institutions
- University of Arizona (US)
- University of California, Los Angeles (US)
- University of Phoenix (US)
- Phoenix College (US)
Publication Details
- Journal
- Quality of Life Research
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1007/s11136-025-04031-9
- Citations
- 1
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Mary Kay Foundation
- Division of Cancer Prevention, National Cancer Institute
- University of Arizona Cancer Center
- National Institutes of Health
- National Cancer Institute